Recurrent BRCA1 and BRCA2 mutations in Mexican women with breast cancer

BACKGROUND: Germline mutations in the BRCA1 and BRCA2 genes confer an estimated 58–80% lifetime risk of breast cancer. In general, screening is done for cancer patients if a relative has been diagnosed with breast or ovarian cancer. There are few data on the prevalence of mutations in these genes in...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Epidemiol Biomarkers Prev
Hlavní autoři: Torres-Mejía, Gabriela, Royer, Robert, Llacuachaqui, Marcia, Akbari, Mohammad R., Giuliano, Anna R., Martínez-Matsushita, Louis, Angeles-Llerenas, Angélica, Ortega-Olvera, Carolina, Ziv, Elad, Lazcano-Ponce, Eduardo, Phelan, Catherine M., Narod, Steven A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4495576/
https://ncbi.nlm.nih.gov/pubmed/25371446
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-13-0980
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky